Home / Brands / Dragon Pharma / Dragon Pharma Kisspeptin 10 mg (Metastin) Research Peptide Vial
Available Domestic
Dragon Pharma Kisspeptin 10 mg (Metastin) Research Peptide Vial
Dragon Pharma

Dragon Pharma Kisspeptin 10 mg (Metastin) Research Peptide Vial

Injection · 10 mg · vial

Out of stock

Dragon Pharma Kisspeptin 10 mg is kisspeptin-10 (metastin), a research peptide supplied as a lyophilised 10 mg vial. It acts as a kisspeptin receptor agonist at the top of the reproductive axis, triggering GnRH release and through it LH and FSH.

Each vial is GMP-manufactured and HPLC-verified, with a Certificate of Analysis on file. Reconstitute with bacteriostatic water. Kisspeptin 10 mg for sale with U.S. domestic and international shipping.

Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted

Product overview

Dragon Pharma Kisspeptin 10 mg - Metastin Research Peptide

Dragon Pharma Kisspeptin 10 mg delivers kisspeptin-10, the peptide also called metastin, as a lyophilised 10 mg vial. It is a research material for laboratory work on the reproductive axis rather than an approved medicine, and the fact sheet records no human label for this form. Kisspeptin 10 mg for sale from a GMP manufacturer, with third-party testing and a Certificate of Analysis on file per batch.

  • Kisspeptin-10 (metastin) - 10 mg per lyophilised vial
  • Ligand of GPR54 (Kiss1R) - stimulates GnRH release
  • Reference half-life about 4 minutes after an intravenous bolus
  • GMP-manufactured, HPLC-verified, COA on file per batch

How Kisspeptin-10 Works

Kisspeptin-10 binds the kisspeptin receptor GPR54, also written Kiss1R, on hypothalamic neurons and drives GnRH secretion. Because GnRH sits above LH and FSH, a bolus moves the whole downstream chain: in healthy men an intravenous bolus raised serum LH and FSH already at 0.3 and 1.0 nmol per kg, while in women the response depended on cycle phase, with no rise in the follicular phase and a clear rise in the preovulatory phase at 10 nmol per kg. That very short action window is why laboratory work uses frequent boluses or infusion instead of one injection.

Research Amounts and Handling

No dose is approved for human use, so every figure below is research practice. Vendor and academic material describes 6 to 10 mcg per kg subcutaneously, flat amounts of 100 to 500 mcg per injection, and infusion protocols of 4 mcg per kg per hour, all from studies of the intravenous peptide. Reconstitute the 10 mg vial with bacteriostatic water: at 2 ml the concentration is 5 mg per ml and a 0.5 mg amount measures 0.1 ml; at 1 ml it is 10 mg per ml and the same amount measures 0.05 ml. Store the powder at 2-8 C away from light. Aldosterone stimulation and injection site reactions are the reported effects.

Quality & Authenticity

Every batch is produced under GMP conditions and checked by independent HPLC, with the Certificate of Analysis held for the batch. The fact sheet lists kisspeptin and its agonists under WADA class S2, prohibited at all times. Kisspeptin is not the same product as PT-141 or the gonadotropin HCG, and it is not a GH secretagogue such as Sermorelin.

For laboratory research only. Consult a healthcare professional before use.

Specifications

Trade NameKisspeptin 10 mg
Generic NameKisspeptin-10 (metastin)
ManufacturerDragon Pharma
Dosage10 mg per lyophilised vial
Package1 vial of powder for reconstitution
Drug ClassResearch peptide, kisspeptin receptor (GPR54) agonist
AdministrationReconstitute with bacteriostatic water, subcutaneous injection
Reference Half-LifeAbout 4 minutes after an intravenous bolus in humans
ShippingInternational and U.S. domestic options

Stacks

Solo Reconstitution Protocol

Reconstitute the 10 mg vial with bacteriostatic water to 5 mg per ml, so a 250 to 500 mcg research amount stays inside a 0.05 to 0.1 ml draw.

Outcome: a measurable small volume instead of guesswork on the syringe.

Note: no human dose is approved. Amounts are research practice from studies of the intravenous form.

Reproductive Axis Research Set

Kisspeptin-10 alongside HCG in one laboratory protocol, with a Sermorelin vial kept as a separate reference.

Outcome: GnRH-driven and gonadotropin-driven signalling are compared side by side.

Note: both compounds shift endogenous hormone output, so results need a baseline to read against.

Consult a healthcare professional before any cycle. Doses are common community protocols.

FAQ

Before you ask

Questions, answered

It is kisspeptin-10, also called metastin, supplied as a lyophilised 10 mg vial. The peptide is an RF-amide ligand of the receptor GPR54, also written Kiss1R, and it stimulates the release of GnRH at the top of the reproductive axis. It is sold as a research-grade material: the fact sheet records no approved human product label for this vial form, so it is not a medicine.

Kisspeptin-10 binds the kisspeptin receptor on hypothalamic neurons and increases GnRH secretion, which in turn drives LH and FSH release. In healthy men an intravenous bolus raised serum LH and FSH at 0.3 and 1.0 nmol per kg. In women the effect depended on cycle phase, with no LH or FSH response in the follicular phase and a rise in the preovulatory phase at 10 nmol per kg.

The fact sheet quotes about four minutes after an intravenous bolus in humans, roughly seven times shorter than kisspeptin-54. That short window is why laboratory work uses frequent boluses or infusion rather than a single injection. The value comes from studies of the intravenous peptide, not from a published profile of a subcutaneous research vial.

No human dose is approved, so every figure is research practice. Vendor and academic material describes 6 to 10 mcg per kg subcutaneously, flat amounts of 100 to 500 mcg per injection, and infusion protocols of 4 mcg per kg per hour, all derived from studies of the intravenous form. A typical reconstitution of this vial is 10 mg of powder in 2 ml of bacteriostatic water, giving 5 mg per ml.

The fact sheet records flushing after a bolus, stimulation of aldosterone, and injection site reactions such as pain or redness. Hepatic load is rated low only because no human hepatotoxicity data were found, so that rating reflects missing data rather than a clean safety record. Systematic human data for a research vial of this kind do not exist.

Keep the lyophilised vial at 2-8 C, protected from light, and avoid repeated freezing and thawing. Add bacteriostatic water down the wall of the vial without shaking. Once reconstituted, keep the solution refrigerated and follow vendor guidance on short use windows, because an exact shelf life for this vial is not confirmed in the sources used here.

No reviews yet

Be the first to share your experience with Dragon Pharma Kisspeptin 10 mg (Metastin) Research Peptide Vial

Log in to write a review